Home > Boards > US Listed > Medical - Drugs > Cerus Corporation (CERS)

* * $CERS Video Chart 11-03-17 * *

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ClayTrader Member Profile
Member Level 
Followed By 8,802
Posts 213,558
Boards Moderated 4
Alias Born 12/27/06
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 7:04:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 7:02:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 7:00:42 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 6:56:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 6:51:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 6:48:18 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/5/2020 6:44:22 PM
Specialized Disclosure Report (sd) Edgar (US Regulatory) - 5/29/2020 4:05:18 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/28/2020 4:10:02 PM
Cerus Corporation Announces FDA PMA Supplement Submission for Pathogen-Reduced Cryoprecipitated Fibrinogen Complex Business Wire - 5/26/2020 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/14/2020 6:23:37 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/5/2020 5:29:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/5/2020 4:05:04 PM
Cerus Corporation Announces First Quarter 2020 Results Business Wire - 5/5/2020 4:01:00 PM
Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Plasma with Alternate Plastic Disposable Kits Business Wire - 5/4/2020 8:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/24/2020 12:06:16 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/24/2020 12:02:44 PM
Cerus Corporation to Release First Quarter 2020 Financial Results on May 5, 2020 Business Wire - 4/24/2020 8:30:00 AM
Cerus Corporation Announces Expansion of BARDA Funding to Support Development of INTERCEPT Blood System for Red Blood Cells Business Wire - 4/20/2020 5:50:00 PM
Cerus Corporation Provides Update on COVID-19 Related Activities Business Wire - 4/6/2020 8:30:00 AM
Cerus Corp. Announces the Inclusion of Pathogen Reduction Technology in the ISBT Working Party Recommendations for the Prepar... Business Wire - 4/2/2020 8:30:00 AM
University Hospital Basel, Switzerland Transfuses First Two COVID-19 Patients With INTERCEPT Treated Coronavirus Convalescent... Business Wire - 4/2/2020 8:30:00 AM
Cerus Forms Group to Research Optimal Production of COVID-19 Convalescent Plasma Business Wire - 3/26/2020 8:30:00 AM
Unknown (sec Staff) Edgar (US Regulatory) - 3/24/2020 1:40:08 PM
Unknown (sec Staff) Edgar (US Regulatory) - 3/24/2020 1:39:33 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist